Details of the Drug Reposition

General Information of This Drug (ID: DMTSRI6)

Drug Name
Oprelvekin   DMTSRI6
Synonyms Neumega; Neumega (TN); Oprelvekin (genetical recombination); Oprelvekin (USAN/INN); Oprelvekin (genetical recombination) (JAN)
Therapeutic Class
Anticoagulants

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
5 Approved Indication(s)
Indication Name Indication ID ICD-11 Status REF
Splenic marginal zone lymphoma DISCGTZY N.A. Approved [1]
MALT lymphoma DIS1AVVE N.A. Approved [1]
Nodal marginal zone lymphoma DIS7MP4T 2A85.0 Approved [1]
Ulcerative colitis DIS8K27O DD71 Approved [1]
Inflammatory bowel disease DISGN23E DD72 Approved [2]
------------------------------------------------------------------------------------
1 Investigative Indication(s)
Indication Name Indication ID ICD-11 Status REF
Thrombocytopenia DISU61YW 3B64 Investigative [3]
------------------------------------------------------------------------------------

References

1 A standard database for drug repositioning. Sci Data. 2017 Mar 14;4:170029.
2 Interleukin-11. BioDrugs. 1997 Dec;8(6):418-29.
3 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6971).